ALLMedicine™ Adnexal Tumors Center
Research & Reviews 102 results
The American Journal of Dermatopathology; Rosales-Duran S, Ricaurte-Jiménez M et. al.
Dec 31st, 2021 - Cutaneous adnexal tumors are benign and malignant neoplasms that undergo morphological differentiation into cutaneous adnexa, comprising pilosebaceous, eccrine, or apocrine units. Reflectance confocal microscopy is a noninvasive diagnostic method ...
BMC Cancer; Hu X, Li D et. al.
Oct 8th, 2021 - To compare the value of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) and magnetic resonance imaging (MRI) in differentiating benign and malignant ovarian or adnexal tumors. English articles reporting on the di...
Journal of Ultrasound in Medicine : Official Journal of T... Haddad L, Kugelman N et. al.
Sep 26th, 2021 - To characterize and compare the sonographic features of exophytic serous borderline ovarian tumors (ESBOT) with those of high-grade serous carcinoma of the ovary (HGSC). Seven patients with histological diagnosis of ESBOT diagnosed between 2011 an...
International Journal of Gynaecology and Obstetrics: the ... Xu A, Nie F et. al.
Sep 13th, 2021 - To evaluate the role of the Simple Rules (SR) from the International Ovarian Tumor Analysis group in contrast-enhanced ultrasound (CEUS) of for the differential diagnosis of benign and malignant adnexal tumors. A total of 180 patients with suspect...
Aug 16th, 2021 - Practice Essentials Pelvic inflammatory disease (PID) is an infectious and inflammatory disorder of the upper female genital tract, including the uterus, fallopian tubes, and adjacent pelvic structures. Infection and inflammation may spread to the...
News 7 results
Charles E. Miller, MD
Sep 4th, 2020 - When an ovarian mass is anticipated or known, following evaluation of a patient’s history and physician examination, imaging via transvaginal and often abdominal ultrasound is the very next step. This evaluation likely will include both gray-scale.
Michele G. Sullivan
May 23rd, 2016 - ORLANDO – Matrilin-2 – a matrix protein found in peritumoral stroma – reliably distinguished invasive basal cell carcinoma from the often difficult-to-distinguish basaloid follicular hamartoma (BFH), in a study that evaluated the protein as a mark.
Salvador Arias-Santiago, MD, José Aneiros-Fernández, MD et. al.
Apr 1st, 2012 - Figure 1. A firm, pink nodule, 10 mm in diameter, with surrounding telangiectasias, at the site of a previous mosquito bite.
Joe R. Monroe, MPAS, PA
Nov 23rd, 2011 - ANSWER The best answer is to send the slides to a dermatopathologist (choice “a”), for reasons that will become clear in the discussion. It is true that by re-excising with margins (choice “b”), the lesion would certainly be gone, but that does n.
Lee PL, Lourduraj LT et. al.
Basaloid follicular hamartoma (BFH) is a benign adnexal tumor consisting of basaloid cells with follicular differentiation. BFH can occur as a solitary lesion, multiple lesions, or an autosomal dominant inherited syndrome—BFH syndrome (BFHS).